InsidersTradesSigma
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (17 ops.)
Insider track record
CEODisclosed buys
1
Disclosed sells
17
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the detailed record of transactions filed by Ostertag Eric, Chief Executive Officer. Insider active across 1 company, notably Poseida Therapeutics, Inc.. Cumulatively, 29 reports have been logged. Breakdown: 1 buy · 17 sells. Total volume traded: €2.6m. Activity tracked since 3 May 2021. The latest transaction was filed on 1 February 2023 (Retenue fiscale). Regulator: SEC (Form 4). The full history is free.
Declarations29 total
11,776 shares@ US$7.001.6% of flowCommon StockSEC:0001209191-23-006828:0
142,857 shares@ US$3.5010.4% of flowCommon StockSEC:0001209191-22-045296:0
Ideal exit: 5 May 2023 (T+270)
160,696 shares@ US$3.68912.3% of flowCommon StockSEC:0001209191-22-044562:0
93,955 shares0Common StockSEC:0001209191-22-006170:0
93,955 shares0Common StockSEC:0001209191-22-006170
1,000 shares@ US$9.150.5% of flowCommon StockSEC:0001209191-21-066229
1,000 shares@ US$9.150.2% of flowCommon StockSEC:0001209191-21-066229:0
9,873 shares@ US$7.091.7% of flowCommon StockSEC:0001209191-21-063934:0
9,873 shares@ US$7.093.4% of flowCommon StockSEC:0001209191-21-063934
18,525 shares@ US$9.158.4% of flowCommon StockSEC:0001209191-21-060403
18,525 shares@ US$9.154.1% of flowCommon StockSEC:0001209191-21-060403:0
10,450 shares@ US$7.021.8% of flowCommon StockSEC:0001209191-21-059651:0
10,450 shares@ US$7.023.6% of flowCommon StockSEC:0001209191-21-059651
20,000 shares@ US$8.0013.8% of flowCommon StockSEC:0001209191-21-057289:0
20,000 shares@ US$8.0012.9% of flowCommon StockSEC:0001209191-21-057289
2,757 shares@ US$1.1730.1% of flowCommon StockSEC:0001209191-21-056246:0
2,757 shares@ US$1.1730.1% of flowCommon StockSEC:0001209191-21-056246
26,686 shares@ US$8.465.3% of flowCommon StockSEC:0001209191-21-054797:0
26,686 shares@ US$8.464.0% of flowCommon StockSEC:0001209191-21-054797
111,149 shares@ US$9.1524.0% of flowCommon StockSEC:0001209191-21-050697:0
111,149 shares@ US$9.1518.1% of flowCommon StockSEC:0001209191-21-050697
7,167 shares@ US$8.131.4% of flowCommon StockSEC:0001209191-21-049673:0
7,167 shares@ US$8.131.0% of flowCommon StockSEC:0001209191-21-049673
10,729 shares@ US$9.771.9% of flowCommon StockSEC:0001209191-21-045591
10,729 shares@ US$9.772.5% of flowCommon StockSEC:0001209191-21-045591:0
25 of 29 declarations
About Ostertag Eric
Eric Ostertag is the Chief Executive Officer of Poseida Therapeutics, Inc.
